-
Founded in:
2016-12-29 -
Country:
China -
Address:
No. 27 Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province -
Tax NO.:
91331002MA28HA6W85 -
Registered Funds:
100 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Atorvastatin calcium |
Atorvastatin is a selective and competitive inhibitor of HMG-CoA reductase. It reduces plasma cholesterol and lipoprotein levels by inhibiting the synthesis of HMG-CoA reductase and cholesterol in the liver, and increases the number of LDL receptors on the surface of liver cells to enhance the uptake and degradation of low-density lipoproteins. It can reduce total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol, triglycerides, and apolipoprotein B levels, while increasing high-density lipoprotein cholesterol and apolipoprotein A-1 levels.
More
Atorvastatin is a selective and competitive inhibitor of HMG-CoA reductase. It reduces plasma cholesterol and lipoprotein levels by inhibiting the synthesis of HMG-CoA reductase and cholesterol in the liver, and increases the number of LDL receptors on the surface of liver cells to enhance the uptake and degradation of low-density lipoproteins. It can reduce total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol, triglycerides, and apolipoprotein B levels, while increasing high-density lipoprotein cholesterol and apolipoprotein A-1 levels. |
134523-03-8 | 110 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sertraline hydrochloride |
This product can selectively inhibit the reuptake of 5-hydroxytryptamine by the central nervous system, thereby increasing the concentration of 5-hydroxytryptamine in the synaptic cleft and exerting an antidepressant effect.
More
This product can selectively inhibit the reuptake of 5-hydroxytryptamine by the central nervous system, thereby increasing the concentration of 5-hydroxytryptamine in the synaptic cleft and exerting an antidepressant effect. |
79559-97-0 | 52 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Atorvastatin calcium |
|
134523-03-8 | 110 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lactobacillin |
It forms a protective layer in the intestine to prevent the invasion of pathogens and viruses; stimulates the intestine to secrete antibodies and improves intestinal immunity; selectively kills intestinal pathogens, protects and promotes the growth of beneficial bacteria; regulates the electrolyte and water balance of the intestinal mucosa; promotes the secretion of gastric juice and enhances digestive function.
More
It forms a protective layer in the intestine to prevent the invasion of pathogens and viruses; stimulates the intestine to secrete antibodies and improves intestinal immunity; selectively kills intestinal pathogens, protects and promotes the growth of beneficial bacteria; regulates the electrolyte and water balance of the intestinal mucosa; promotes the secretion of gastric juice and enhances digestive function. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Doxazosin |
Doxazosin is a selective α-receptor blocker. It selectively and competitively blocks postganglionic α1-adrenergic receptors to dilate blood vessels, reduce vascular resistance, and lower blood pressure. Doxazosin is an effective blocker of the A1 subtype of α1-adrenergic receptors, and more than 70% of prostate α1 receptors are A1 subtypes. Therefore, it can improve the symptoms of benign prostatic hyperplasia by selectively blocking α1-adrenergic receptors (mainly A1 subtypes) located in the matrix, capsule, and bladder neck smooth muscle. Doxazosin can moderately increase the ratio of high-density lipoprotein cholesterol to total cholesterol, but its clinical significance has not yet been determined. In vitro studies have shown that 5μmol of doxazosin 6,- and 7,-hydroxylated metabolites have antioxidant effects.
More
Doxazosin is a selective α-receptor blocker. It selectively and competitively blocks postganglionic α1-adrenergic receptors to dilate blood vessels, reduce vascular resistance, and lower blood pressure. Doxazosin is an effective blocker of the A1 subtype of α1-adrenergic receptors, and more than 70% of prostate α1 receptors are A1 subtypes. Therefore, it can improve the symptoms of benign prostatic hyperplasia by selectively blocking α1-adrenergic receptors (mainly A1 subtypes) located in the matrix, capsule, and bladder neck smooth muscle. Doxazosin can moderately increase the ratio of high-density lipoprotein cholesterol to total cholesterol, but its clinical significance has not yet been determined. In vitro studies have shown that 5μmol of doxazosin 6,- and 7,-hydroxylated metabolites have antioxidant effects. |
74191-85-8 | 6 |